Natixis Illumina, Inc. Transaction History

Natixis

  • $17.6 Billion
  • Q3 2024

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$101.05 - $133.57 $4.4 Million - $5.81 Million
-43,521 Reduced 17.87%
200,029 $20.9 Million
Q1 2024

May 13, 2024
BUY
$127.73 - $147.2 $29.8 Million - $34.4 Million
233,641 Added 2357.87%
243,550 $33.4 Million
Q4 2023

Feb 13, 2024
SELL
$92.79 - $142.53 $5.86 Million - $9 Million
-63,171 Reduced 86.44%
9,909 $1.38 Million
Q3 2023

Nov 14, 2023
BUY
$128.91 - $192.44 $9.42 Million - $14.1 Million
73,080 New
73,080 $10 Million
Q4 2022

Feb 24, 2023
SELL
$187.24 - $242.74 $138,557 - $179,627
-740 Reduced 3.58%
19,917 $4.03 Million
Q4 2022

Feb 13, 2023
BUY
$187.24 - $242.74 $359,688 - $466,303
1,921 Added 10.25%
20,657 $4.18 Million
Q3 2022

Nov 14, 2022
SELL
$177.23 - $227.44 $1.78 Million - $2.28 Million
-10,029 Reduced 34.87%
18,736 $3.59 Million
Q2 2022

Aug 12, 2022
SELL
$181.58 - $368.0 $6.56 Million - $13.3 Million
-36,145 Reduced 55.68%
28,765 $5.32 Million
Q1 2022

May 13, 2022
BUY
$303.87 - $423.8 $5.26 Million - $7.34 Million
17,318 Added 36.39%
64,910 $22.7 Million
Q4 2021

Feb 14, 2022
BUY
$347.28 - $421.83 $1.95 Million - $2.37 Million
5,623 Added 13.4%
47,592 $18.1 Million
Q3 2021

Nov 12, 2021
BUY
$405.61 - $524.84 $12.2 Million - $15.8 Million
30,182 Added 256.06%
41,969 $17 Million
Q2 2021

Aug 13, 2021
BUY
$372.84 - $481.5 $954,843 - $1.23 Million
2,561 Added 27.76%
11,787 $5.58 Million
Q1 2021

May 14, 2021
SELL
$361.28 - $504.76 $4.06 Million - $5.67 Million
-11,237 Reduced 54.91%
9,226 $3.54 Million
Q4 2020

Feb 12, 2021
SELL
$292.7 - $370.96 $3.79 Million - $4.81 Million
-12,965 Reduced 38.78%
20,463 $7.57 Million
Q3 2020

Nov 12, 2020
SELL
$268.51 - $400.74 $25.4 Million - $37.8 Million
-94,450 Reduced 73.86%
33,428 $10.3 Million
Q2 2020

Aug 13, 2020
BUY
$256.46 - $373.01 $29.1 Million - $42.3 Million
113,504 Added 789.65%
127,878 $47.4 Million
Q1 2020

May 14, 2020
BUY
$209.2 - $335.53 $132,632 - $212,726
634 Added 4.61%
14,374 $3.93 Million
Q4 2019

Feb 14, 2020
SELL
$288.29 - $335.49 $19.4 Million - $22.6 Million
-67,420 Reduced 83.07%
13,740 $4.51 Million
Q3 2019

Nov 13, 2019
SELL
$266.84 - $378.23 $7.52 Million - $10.7 Million
-28,174 Reduced 25.77%
81,160 $24.7 Million
Q2 2019

Aug 13, 2019
BUY
$300.59 - $368.15 $27.2 Million - $33.3 Million
90,540 Added 481.75%
109,334 $40.3 Million
Q1 2019

May 15, 2019
BUY
$272.57 - $321.18 $4.42 Million - $5.2 Million
16,199 Added 624.24%
18,794 $5.74 Million
Q4 2018

Feb 14, 2019
SELL
$272.46 - $366.54 $4.84 Million - $6.51 Million
-17,748 Reduced 87.24%
2,595 $778,000
Q3 2018

Nov 14, 2018
BUY
$279.04 - $367.06 $5.68 Million - $7.47 Million
20,343 New
20,343 $7.47 Million
Q1 2018

May 15, 2018
SELL
$209.54 - $253.91 $1.92 Million - $2.33 Million
-9,167 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$202.23 - $230.03 $1.85 Million - $2.11 Million
9,167 New
9,167 $2 Million
Q3 2017

Nov 14, 2017
SELL
$172.3 - $213.93 $14.5 Million - $18 Million
-84,214 Closed
0 $0
Q2 2017

Aug 14, 2017
BUY
N/A
84,214
84,214 $14.6 Million

Others Institutions Holding ILMN

# of Institutions
908
Shares Held
138M
Call Options Held
1.22M
Put Options Held
1.43M
View Full List

About ILLUMINA, INC.

ILMN Quotes by TradingView
  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $20.9B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Natixis Portfolio

Follow Natixis and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email